MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 47 filers reported holding MILESTONE PHARMACEUTICALS IN in Q2 2023. The put-call ratio across all filers is 61.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $490 | – | 172 | +73.7% | 0.00% | – |
| Q1 2023 | $0 | -100.0% | 99 | -92.1% | 0.00% | – |
| Q4 2022 | $5 | -99.9% | 1,247 | +124.7% | 0.00% | – |
| Q4 2021 | $4,000 | +300.0% | 555 | +277.6% | 0.00% | – |
| Q3 2021 | $1,000 | -88.9% | 147 | -90.6% | 0.00% | – |
| Q2 2021 | $9,000 | +28.6% | 1,566 | +42.9% | 0.00% | – |
| Q4 2020 | $7,000 | 0.0% | 1,096 | +19.7% | 0.00% | – |
| Q3 2020 | $7,000 | -22.2% | 916 | -62.2% | 0.00% | – |
| Q2 2020 | $9,000 | +350.0% | 2,423 | +1606.3% | 0.00% | – |
| Q4 2019 | $2,000 | -33.3% | 142 | -4.7% | 0.00% | – |
| Q3 2019 | $3,000 | -94.1% | 149 | -92.1% | 0.00% | -100.0% |
| Q2 2019 | $51,000 | – | 1,877 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 2,530,585 | $16,955,000 | 0.73% |
| Ikarian Capital, LLC | 1,836,545 | $12,305,000 | 0.54% |
| Boxer Capital, LLC | 2,477,194 | $16,597,000 | 0.53% |
| RTW INVESTMENTS, LP | 4,315,102 | $28,911,000 | 0.48% |
| RA Capital Management | 2,327,714 | $15,596,000 | 0.22% |
| Orbimed Advisors | 2,493,109 | $16,704,000 | 0.15% |
| PURA VIDA INVESTMENTS, LLC | 450,000 | $3,015,000 | 0.11% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 851,291 | $5,704,000 | 0.08% |
| Anson Funds Management LP | 50,113 | $336,000 | 0.07% |
| Tekla Capital Management LLC | 253,610 | $1,699,000 | 0.06% |